FDA EIR - Mol Logistics (USA) Inc. - October 20, 2021

An FDA surveillance inspection was conducted at MOL LOGISTICS (USA) INC., located in Fairview, NJ, on October 20, 2021. This was the initial inspection for the firm, which operates as a warehouse for various products, including Japanese specialty soy sauce, monosodium glutamate, diphenhydramine hydrochloride, and mica. The inspection was carried out by a representative of the New Jersey Department of Health under an FDA contract agreement. It followed established guidance for Preventive Controls and Sanitary Human Food Operations (CPGM 7303.040). Key regulatory considerations included the FSMA Final Rule on Preventive Controls for Human Foods, the Sanitary Transportation of Human and Animal Food, and the Final Rule for Mitigation Strategies to Protect Food Against Intentional Adulteration. Significantly, the inspection found no deficiencies, indicating full compliance with applicable regulations. Consequently, the firm received a "No Action Indicated" (NAI) classification from the FDA and a "Satisfactory" rating from the NJDOH. No violations or significant issues were identified, and therefore, no immediate corrective actions were required. The only recommendation was for a routine re-inspection to be conducted when permitted by the inspection workplan.